In advanced SLE, lower serum MMP-9 and higher TIMP-1 levels indicate a shift toward proteolytic inhibition, which may promote antigen accumulation when non-selective MMP inhibitors are used [45]. The gene discussed is TIMP1; the disease is systemic lupus erythematosus.